about
Trends in pharmacological therapy following an acute coronary syndrome in Portugal: a systematic review.The use of reperfusion and revascularization procedures in acute coronary syndrome in Portugal: a systematic review.Disability-adjusted life years lost due to ischemic heart disease in mainland Portugal, 2013.Alcohol consumption in Mozambique: regular consumption, weekly pattern and binge drinking.Low fruit and vegetable consumption in Mozambique: results from a WHO STEPwise approach to chronic disease risk factor surveillance.Prognostic Value of Osteoprotegerin in Acute Heart Failure.Sex-related inequalities in management of patients with acute coronary syndrome-results from the EURHOBOP study.Missed Opportunities in Symptomatic Patients before a First Acute Coronary Syndrome: The EPIHeart Cohort Study.Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction.Prognostic Effect of the Dose of Loop Diuretic Over 5 Years in Chronic Heart Failure.Measuring renal function in acute heart failure: A place for old and new equations.Sex differences in presenting symptoms of acute coronary syndrome: the EPIHeart cohort study.Validity of the Seattle Heart Failure Model for prognosis in a population at low coronary heart disease riskPrognostic value of worsening renal function in outpatients with chronic heart failureHigher BMI in heart failure patients is associated with longer survival only in the absence of diabetesHeart failure with reduced ejection fraction: Should we submit patients without angina to coronary angiography?Serum creatinine trajectories in real-world hospitalized patients: clinical context and short-term mortalityPrognostic Effect of Renal Function in Ambulatory Patients With Heart Failure and Reduced Ejection Fraction: The Kidney Is a Marker of Cardiac FunctionEarly prediction of treatment failure in severe community-acquired pneumonia: The PRoFeSs score
P50
Q30252105-312BD9B4-642E-4BF1-9AEE-DE938FA3C8C5Q38279647-4CEAB412-6BFB-4324-A919-D0C9B4B87F0FQ38894082-99021D61-22C2-402D-8006-5843D23905CEQ39810966-A9F1C1E4-91AA-4725-AA75-29F30458BBE1Q39991189-8597F4C4-38A6-47D7-9E3D-F7DCCD6BBFC1Q40768454-7CF31B79-6D22-416F-A78B-D5D8DE7F2A32Q47260286-CE863295-D90A-4CC7-A0B6-B8716F65A220Q47570107-5BF7A1A8-C6B2-4E5D-AC2C-5BA25E5096F8Q48377344-8C439866-62F2-415E-AF39-D44B38DEE698Q50740768-683C18DD-5DA5-4FEB-A1CC-7359ECFF9B6AQ50899183-C76EC2BB-FA3F-4D67-A9EF-50A5F3557947Q53841520-5D11CB4A-B166-4F27-B9F9-266D068D3D88Q58873444-0162E5FD-A550-4ECA-8344-53613733470BQ59380372-787A7D84-4853-4BBB-83A2-819760EFDF4EQ59380388-EA14C6BA-7B3F-49A5-BE3D-FE3D27EAF8BFQ87199731-E60FF925-942E-4BBC-87DA-0112F8ABD7B4Q90369875-7B9CBF7E-53AA-491D-B35A-F452A0EB342CQ91366892-0A047F3D-6475-438B-8948-E296FE0960A1Q92606708-5355585B-80C8-455E-99D4-1A3D5F9F205A
P50
description
Pools onderzoekster
@nl
researcher, ORCID id # 0000-0001-7786-9431
@en
name
Olga Laszczyńska
@ast
Olga Laszczyńska
@ca
Olga Laszczyńska
@de
Olga Laszczyńska
@en
Olga Laszczyńska
@es
Olga Laszczyńska
@fr
Olga Laszczyńska
@ga
Olga Laszczyńska
@gl
Olga Laszczyńska
@it
Olga Laszczyńska
@nl
type
label
Olga Laszczyńska
@ast
Olga Laszczyńska
@ca
Olga Laszczyńska
@de
Olga Laszczyńska
@en
Olga Laszczyńska
@es
Olga Laszczyńska
@fr
Olga Laszczyńska
@ga
Olga Laszczyńska
@gl
Olga Laszczyńska
@it
Olga Laszczyńska
@nl
prefLabel
Olga Laszczyńska
@ast
Olga Laszczyńska
@ca
Olga Laszczyńska
@de
Olga Laszczyńska
@en
Olga Laszczyńska
@es
Olga Laszczyńska
@fr
Olga Laszczyńska
@ga
Olga Laszczyńska
@gl
Olga Laszczyńska
@it
Olga Laszczyńska
@nl
P106
P1153
38061547700
P1412
P21
P27
P31
P496
0000-0001-7786-9431